Drugs Used in TB and Leprosy

Meenakshi R. Ramanathan, James M. Sanders

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

4 Scopus citations


Multidrug resistance continues to be a problem in the treatment of tuberculosis (TB). With more cases of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB), clinicians are reverting to second-line and third-line agents, which have proven to be more toxic in nature and costly. This chapter reviews the 2016 data on the side effect profiles of commonly used medications in Mycobacterium tuberculosis and Mycobacterium leprae infections. Medications covered in this chapter include bedaquiline, capreomycin, clofazamine, cycloserine, dapsone, delamanid, ethambutol, gatifloxacin, isoniazid, kanamycin, levofloxacin, moxifloxacin, pyrazinamide, and the rifamycins.

Original languageEnglish
Title of host publicationSide Effects of Drugs Annual
PublisherElsevier B.V.
Number of pages11
StatePublished - 1 Jan 2017

Publication series

NameSide Effects of Drugs Annual
ISSN (Print)0378-6080


  • Adverse effects
  • Ethambutol
  • Isoniazid
  • Leprosy
  • Pyrazinamide
  • Rifamycins
  • Side effects
  • Tuberculosis


Dive into the research topics of 'Drugs Used in TB and Leprosy'. Together they form a unique fingerprint.

Cite this